Journal Article

39ORibociclib (RIB) + non-steroidal aromatase inhibitor (NSAI) + goserelin in premenopausal Asian women with hormone-receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC): Results from the randomized phase III MONALEESA-7 study

S-A Im, J Sohn, D Tripathy, L Chow, K S Lee, K H Jung, G Babu, Y-H Im, N El Saghir, M-C Liu, I Diaz-Padilla, J Alam, O Kong, M Miller and Y-S Lu

in Annals of Oncology

Published on behalf of European Society Medical Oncology

Volume 29, issue suppl_9 Published in print November 2018 | ISSN: 0923-7534
Published online November 2018 | e-ISSN: 1569-8041 | DOI: https://dx.doi.org/10.1093/annonc/mdy428
39ORibociclib (RIB) + non-steroidal aromatase inhibitor (NSAI) + goserelin in premenopausal Asian women with hormone-receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC): Results from the randomized phase III MONALEESA-7 study

Show Summary Details

Journal Article.  629 words. 

Subjects: Medical Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or purchase to access all content.